Immunome Inc. Files 8-K on Financials
Ticker: IMNM · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1472012
| Field | Detail |
|---|---|
| Company | Immunome Inc. (IMNM) |
| Form Type | 8-K |
| Filed Date | Mar 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Immunome dropped an 8-K detailing its financial and operational results.
AI Summary
Immunome, Inc. filed an 8-K on March 19, 2025, reporting on its results of operations and financial condition, as well as financial statements and exhibits. The filing provides an update on the company's financial status and operational performance.
Why It Matters
This filing provides investors with crucial updates on Immunome's financial health and operational performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- Immunome, Inc. (company) — Registrant
- March 19, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-39580 (identifier) — SEC File Number
- 77-0694340 (identifier) — I.R.S. Employer Identification No.
- 18702 N. Creek Parkway, Suite 100 Bothell, WA 98011 (address) — Principal executive offices
- ( 425 ) 939-7410 (phone_number) — Registrant's telephone number
FAQ
What specific financial results are being reported in this 8-K?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits', but the specific figures are not detailed in the provided text.
When was the earliest event reported in this filing?
The earliest event reported is dated March 19, 2025.
What is Immunome, Inc.'s state of incorporation?
Immunome, Inc. is incorporated in Delaware.
What is the SEC file number for Immunome, Inc.?
The SEC file number for Immunome, Inc. is 001-39580.
Where are Immunome, Inc.'s principal executive offices located?
Immunome, Inc.'s principal executive offices are located at 18702 N. Creek Parkway, Suite 100, Bothell, WA 98011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Immunome Inc. (IMNM).